Phreesia Inc PHR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption
-
CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence
-
Phreesia Announces Second Quarter Fiscal 2025 Results
-
Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination
-
Bob Glazer Joins Phreesia as Strategic Advisor
-
Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm
-
Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results
-
Phreesia Now Available on Oracle Healthcare Marketplace
Trading Information
- Previous Close Price
- $22.74
- Day Range
- $22.60–23.44
- 52-Week Range
- $12.07–29.14
- Bid/Ask
- $22.48 / $22.64
- Market Cap
- $1.31 Bil
- Volume/Avg
- 121,641 / 403,665
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.28
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.11%
Company Profile
Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,438
- Website
- https://www.phreesia.com
Comparables
Valuation
|
Metric
|
PHR
|
RCM
|
OMCL
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 93.51 | 28.87 |
Price/Book Value | 5.22 | 2.12 | 1.65 |
Price/Sales | 3.28 | 2.61 | 1.82 |
Price/Cash Flow | 392.50 | 15.96 | 15.70 |
Price/Earnings
PHR
RCM
OMCL
Financial Strength
|
Metric
|
PHR
|
RCM
|
OMCL
|
|---|---|---|---|
Quick Ratio | 1.65 | 1.51 | 1.99 |
Current Ratio | 1.77 | 1.84 | 2.45 |
Interest Coverage | −43.21 | 0.86 | — |
Quick Ratio
PHR
RCM
OMCL
Profitability
|
Metric
|
PHR
|
RCM
|
OMCL
|
|---|---|---|---|
Return on Assets (Normalized) | −12.32% | 1.83% | 3.03% |
Return on Equity (Normalized) | −17.69% | 3.51% | 5.73% |
Return on Invested Capital (Normalized) | −16.98% | 4.47% | 2.80% |
Return on Assets
PHR
RCM
OMCL
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock
GEHC
| Lttrbrp | Lxzd | $42.0 Bil | |||
| Veeva Systems Inc Class A
VEEV
| Hkybtmnnr | Xbwy | $34.1 Bil | |||
| Pro Medicus Ltd
PMCUF
| — | Xjrmdrw | $12.5 Bil | |||
| Solventum Corp
SOLV
| — | Jqtpnz | $11.7 Bil | |||
| Tempus AI Inc Class A common stock
TEM
| — | Mdzf | $8.3 Bil | |||
| Doximity Inc Class A
DOCS
| — | Zpdvvyd | $8.0 Bil | |||
| M3 Inc
MTHRF
| — | Dnzyc | $7.1 Bil | |||
| M3 Inc ADR
MTHRY
| — | Jbjywh | $7.1 Bil | |||
| HealthEquity Inc
HQY
| — | Cmgsy | $7.0 Bil | |||
| R1 RCM Inc
RCM
| — | Vgdg | $6.0 Bil |
United States